Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Silylation Protection. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1990450A details a selective silylation route for high-purity prostaglandin intermediates, offering significant cost reduction in ophthalmic API manufacturing.